Soluble CD8 and ICAM-1 in serum and CSF of MS patients treated with 6-methylprednisolone

Acta Neurologica Scandinavica

Volumn 95, Issue 5, 1997, Pages 275-279

  Franciotta, D ^a,b   Piccolo, G ^a   Zardini, E ^a   Bergamaschi, R ^a   Cosi, V ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

Cerebrospinal fluid; Methylprednisolone; Multiple sclerosis; Soluble CD8; Soluble ICAM 1

Indexed keywords

CD8 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; METHYLPREDNISOLONE;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTIPLE SCLEROSIS; RELAPSE;

EID: 0031010247     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1997.tb00209.x     Document Type: Article

References (32)

1. FABRY Z, RAINE CS, HART MN. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol Today 1994: 15: 218-24.
2. lck. Cell 1988: 55: 301-8.
3. KAPLAN DR, HAMBOR JE, TYKOCINSKI ML. An immunoregulatory function for the CD8 molecule. Proc Natl Acad Sci USA 1989: 86: 8512-15.
4. MARLIN SD, SPRINGER TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen-1 (LFA-1). Cell 1987: 51: 813-19.
5. ROSSLER K, NEUCHRIST C, KITZ O et al. Expression of leukocyte adhesion molecules at the human blood-brain barrier (BBB). J Neurosci Res 1992: 3: 364-74.
6. CANNELLA B, RAINE CS. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 1995: 37: 424-35.
7. ROTHLEIN R, MAINOLFI EA, CZAIKOWSKI M, MARLIN SD. A form of circulating ICAM-1 in human serum. J Immunol 1991: 147: 3788-93.
8. TSUJISAKI M, IMAI K, HIRATA H et al. Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases. Clin Exp Immunol 1991: 85: 3-8.
9. MAIMONE D, REDER AT. Soluble CD8 levels in the CSF and serum of patients with multiple sclerosis. Neurology 1991: 41: 851-4.
10. CARRIERI PB, SOSCIA E, IACOVITTI B et al. Soluble interleukin-2 receptor and soluble CD8 molecules in cerebrospinal fluid and serum of patients with multiple sclerosis. Eur Cytokine Netw 1992: 3: 495-8.
11. HARTUNG H-P, MICHELS M, REINERS K, SEELDRAYERS P, ARCHELOS JJ, TOYKA KV. Soluble ICAM-1 serum levels in multiple sclerosis and viral encephalitis. Neurology 1993: 43: 2331-5.
12. SHARIEF MK, NOORI MA, CIARDI M, CIRELLI A, THOMPSON EJ. Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage. J Neuroimmunol 1993: 43: 15-21.
13. TSUKADA N, MATSUDA M, MIYAGI K, YANAGISAWA N. Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis. Neurology 1993: 43: 2679-82.
14. TSUKADA N, MIYAGI K, MATSUDA M, YANAGISAWA N. Increased levels of circulating intercellular adhesion molecule-1 in multiple sclerosis and human T-lymphotropic virus type-I-associated myelopathy. Ann Neurol 1993: 33: 646-9.
15. RIECKMANN P, MARTIN S, WEICHSELBRAUN I et al. Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse. Neurology 1994: 44: 2367-72.
16. DORE-DUFFY P, NEWMAN W, BALABANOV R et al. Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity. Ann Neurol 1995: 37: 55-62.
17. COMPSTON A. Methylprednisolone and multiple sclerosis. Arch Neurol 1988: 45: 669-70.
18. POSER CM, PATY DW, SCHEINBERG L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983: 13: 227-31.
19. KURTZKE JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983: 33: 1444-52.
20. TIBBLING G, LINK H, OHMAN S. Principles of albumin and IgG analysis in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 1977: 37: 385-90.
21. TOURTELLOTTE WW, POTVIN AR, FLEMING JO et al. Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate. Neurology 1980: 30: 240-4.
22. SOBEL RA, MITCHELL ME, FONDREN G. Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am J Pathol 1990: 136: 1309-16.
23. CANNELLA B, CROSS AH, RAINE CS. Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system. J Exp Med 1990: 172: 1521-4.
24. ARCHELOS JJ, JUNG S, MÄURER M et al. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann Neurol 1993: 34: 145-54.
25. TOMKINSON BE, BROWN MC, IP SH, CARRABIS S, SULLIVAN JL. Soluble CD8 during T cell activation. J Immunol 1989: 142: 2230-6.
26. GRIFFIN DE, MCARTHUR JC, CORNBLATH DR. Soluble interleukin-2 receptor and soluble CD8 in serum and cerebrospinal fluid during human immunodeficiency virus-associated neurologic disease. J Neuroimmunol 1990: 28: 97-109.
27. SYMONS JA, WOOD NC, DI GIOVINE FS, DUFF GW. Soluble CD8 in patients with rheumatic diseases. Clin Exp Immunol 1990: 80: 354-9.
28. OLSSON T, BAKHIET M, HOJEBERG B et al. CD8 is critically involved in lymphocyte activation by a T. brucei brucei-released molecule. Cell 1993: 72: 715-27.
29. JAKOBSEN PH, MORRIS-JONES S, THEANDER TG et al. Increased plasma levels of soluble IL-2R are associated with severe Plasmodium falciparum malaria. Clin Exp Immunol 1994: 96: 98-103.
30. PANITCH HS, HIRSCH RL, HALEY AS, JOHNSON KP Exacerbation of multiple sclerosis in patients treated with gamma interferon. Lancet 1987: 1: 893-5.
31. + T cells in murine experimental allergic encephalomyelitis. Science 1992: 256: 1213-5.
32. HUGHES RAC, SHARRACK B. More immunotherapy for multiple sclerosis. J Neurol Neurosurg Psychiatry 1996: 61: 239-41.